Anti-PTPRZ1 CAR-M (Southwest Hospital)

N/A

Report date: 2026/04/21 20:00:18

Base Information

Drug NameAnti-PTPRZ1 CAR-M (Southwest Hospital)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Macrophages therapy > Chimeric antigen receptor Macrophages therapy
Mechanisms of ActionAnti-Receptor-type tyrosine-protein phosphatase zeta
TargetsReceptor-type tyrosine-protein phosphatase zeta
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesThe Southwest Hospital of AMU
China Registration ClassN/A

Develop Information

Active CompaniesThe Southwest Hospital of AMU
Inactive CompaniesN/A
Active IndicationsLung Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A